Overview

This trial is active, not recruiting.

Condition nosocomial infection
Treatment bundling infection control interventions
Sponsor Mahidol University
Start date January 2009
End date July 2009
Trial size 2000 participants
Trial identifier NCT00917319, Siriraj CEU 52-001, Siriraj Hospital

Summary

Bundling infection control interventions should decrease incidence of Healthcare-Associated Infections in General Medical Wards at Siriraj Hospital, Bangkok, Thailand

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification efficacy study
Intervention model parallel assignment
Masking open label
Primary purpose prevention
Arm
(Experimental)
Bundling Infection Control Interventions
bundling infection control interventions
identify risk factors for developing HAIs, receive general infection control measures as well as infection control measures appropriate for the identified risk factor (s)

Primary Outcomes

Measure
Incidence of healthcare-associated infection
time frame: 7 months

Secondary Outcomes

Measure
Incidence of hospital-acquired pneumonia and catheter-associated UTI
time frame: 7 months

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - The patients hospitalized to general medical wards Exclusion Criteria: - The patients hospitalized less than 48 hours

Additional Information

Official title Randomized Controlled Study on Effectiveness of Implementing Bundling Infection Control Interventions for Prevention and Control of Healthcare-Associated Infections in General Medical Wards at Siriraj Hospital, Bangkok, Thailand
Principal investigator Visanu Thamlikitkul, MD
Trial information was received from ClinicalTrials.gov and was last updated in June 2009.
Information provided to ClinicalTrials.gov by Mahidol University.